Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lee D Cranmer
Vorinostat Synergizes With Ridaforolimus and Abrogates the Ridaforolimus-Induced Activation of AKT in Synovial Sarcoma Cells
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Serum Protein Acidic and Rich in Cysteine (SPARC) as a Prognostic Marker in Soft Tissue Sarcomas
Clinical Sarcoma Research
Oncology
Related publications
Phase I Study of the mTOR Inhibitor Ridaforolimus and the HDAC Inhibitor Vorinostat in Advanced Renal Cell Carcinoma and Other Solid Tumors
Investigational New Drugs
Oncology
Pharmacology
A Phase I Trial of Combined Ridaforolimus and MK-2206 in Patients With Advanced Malignancies
Clinical Cancer Research
Cancer Research
Oncology
Synergistic Activity of the mTOR Inhibitor Ridaforolimus and the Antiandrogen Bicalutamide in Prostate Cancer Models
International Journal of Oncology
Cancer Research
Oncology
A Phase 1 Study of Oral Ridaforolimus in Pediatric Patients With Advanced Solid Tumors
Oncotarget
Oncology
Activation of ERK1/2 Causes Pazopanib Resistance via Downregulation of DUSP6 in Synovial Sarcoma Cells
Scientific Reports
Multidisciplinary
Safety and Preliminary Efficacy Analysis of the mTOR Inhibitor Ridaforolimus in Patients With Taxane-Treated, Castration-Resistant Prostate Cancer
Clinical Genitourinary Cancer
Oncology
Urology
CD81 Mediated Regulation of Synoviolin Expression in Synovial Sarcoma Cells
Journal of Hard Tissue Biology
Sports Medicine
Cell Biology
Biochemistry
Orthopedics
Biomaterials
Dentistry
Medicine
FcγRIIb Modulation of Surface Immunoglobulin-Induced Akt Activation in Murine B Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Genetic Deletion of PKR Abrogates TNF-induced Activation of IκBα Kinase, JNK, Akt and Cell Proliferation but Potentiates P44/P42 MAPK and P38 MAPK Activation
Oncogene
Cancer Research
Genetics
Molecular Biology
